Investor Presentaiton slide image

Investor Presentaiton

Oregon's Drug Price Transparency Program The Prescription Drug Transparency Act (HB 4005), enacted during the 2018 Legislative Session, established Oregon's Drug Price Transparency program Increase transparency on prescription drug costs and prices from pharmaceutical manufacturers Collect prescription drug information from health insurance companies Provide consumers a way to report personal prescription drug price increases 3
View entire presentation